Strategic alliance formed between Groupe Grimaud and Newsham Choice Genetics

West Des Moines - Iowa, USA (Newsham) and Groupe Grimaud, France (Grimaud), have entered into an agreement to form a long term strategic alliance.

Newsham is currently the 2nd largest supplier of swine genetics in the North American market.

Grimaud is the 2nd largest multi-species poultry genetics group supplying customers in more than 100 countries from its European, US, Brazilian and Asian facilities.

Under the terms of the agreement, Grimaud takes an important interest in Bucolica BV, the Netherlands based company holding a major interest in Newsham. The Newsham original ownership: Bucolica, the Mitchell family, and key Newsham employees remain in control.

This powerful alliance strengthens the acceleration of Newsham’s business development outside North America and seeks synergies in the field of research and development.

Newsham Choice Genetics has extensive experience in the North American market, supplemented by the recent acquisition of Monsanto Choice Genetics. Newsham will continue to develop its R&D and commercial activities in the swine genetics business through maintaining the original focus on North America as well as pursuing selective expansion in new markets in collaboration with the global network of Grimaud.

Grimaud’s investment in Bucolica occurs through its new holding, "Pig Genetics Development Company", which will be the vehicle for its development in the swine genetics business particularly in Europe and Asia, headed by Pieter Seghers who has extensive experience in this industry.

Frédéric Grimaud, president of Groupe Grimaud declares: "I am very pleased with this agreement. It fits perfectly with our long term strategy to develop a global animal multi-species genetics group. This alliance brings a new promising dimension into our Group.”

Brent Mitchell, Co-CEO of Newsham says: "Newsham Choice Genetics has excellent products and technologies which now can be offered to the pig industry on a worldwide basis through the alliance with the Grimaud Group."

Mark Weaver, Co-CEO of Newsham explains: "We expect further synergies from this alliance. Both groups have a strong focus on technology, and we believe that the interaction of the two independent science based teams will lead to new R&D results."

______________________________________________